semaglutide news october 20 2025 Most quit breakthrough weight-loss drug within a year Oral Wegovy approved for obesity

Do you have to be on semaglutide forever

D.GralnickJ

A 2023 systematic review published in Frontiers in Endocrinology found that GLP-1 receptor agonists significantly improved weight, waist circumference, and insulin resistance markers in women with PCOS, reinforcing their growing role in metabolic management

While both medications are designed to help with weight loss and blood sugar management, there are some key differences

Individuals with Gastrointestinal Disorders: Such as Crohns disease, celiac disease, atrophic gastritis, or those who have had gastric bypass surgery or other stomach/intestinal resections, which can interfere with B12 absorption

Place the vial upright in a consistent location, away from temperature fluctuations near the door or freezer compartment